Trial intelligence / Profile preview

Thiamine for prevention of postoperative delirium in elderly major abdominal surgery

ChiCTR2600121658Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of University of Science and Technology of China
Start
Apr 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of thiamine in postoperative delirium (POD) (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Incidence of delirium within 7 days after surgery. Planned start Apr 2026; status: not yet recruiting.

02

Drugs

thiamine
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on ChiCTR2600121658.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600121658.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call